Top Section/Ad
Top Section/Ad
Most recent
Two big infrastructure deals with private capital providers are fuelling hopes of a sustained M&A rebound in Germany
SMG’s drop below offer price sends mixed signals
SMG pares back gains after year’s largest IPO, Verisure to follow
Italy’s top independent investment bank must try to survive inside Monte dei Paschi
More articles/Ad
More articles/Ad
More articles
-
UK chancellor of the exchequer Rishi Sunak is looking at ways to relax listing rules on the London Stock Exchange to make the exchange more attractive for tech company IPOs. -
Chinese cosmetics company Yatsen Holdings saw its shares spike 75% on their New York Stock Exchange debut on Thursday, after the firm priced its IPO at the top of the marketed range.
-
Syncona, the UK life sciences investor, has launched a new gene therapy company, through a £45m series A private fundraising round. The company could be a future candidate for a lucrative biotech listing.
-
Diaverum, the Swedish operator of kidney dialysis clinics, has launched an IPO on the Nasdaq Stockholm.
-
Swedish digital bank Nordnet has set a price range for its IPO on Nasdaq Stockholm, following a constructive investor education process.
-
Chinese beauty company Yatsen Holding has set its New York Stock Exchange IPO in motion, kicking off bookbuilding for a $616.9m listing.
